Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05955482 · ClinicalTrials.gov registry record
Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients With Chronic Obstructive Pulmonary Disease
A clinical trial of COPD and Comorbidities and Coexisting Conditions, sponsored by NuvoAir Medical PC.
- Active
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05955482: Active study of COPD and Comorbidities and Coexisting Conditions, sponsored by NuvoAir Medical PC.
NCT05955482 is a study of COPD and Comorbidities and Coexisting Conditions that is active but no longer recruiting, run by NuvoAir Medical PC. The registered enrollment target is 300 participants, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05955482, a study of COPD and Comorbidities and Coexisting Conditions, is active but no longer recruiting, sponsored by NuvoAir Medical PC.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 12 month study of up to 500 people with COPD to determine if the NuvoAir clinical service leads to lower rates of severe COPD exacerbations, hospitalizations, emergency room visits, and total cost of care compared to a similar group that doesn't receive care from the NuvoAir clinical service.
Primary Outcome
Rate of moderate and severe exacerbations of COPD, measured by the health insurer or provider's records.
Conditions Studied
Interventions
- OTHER NuvoAir Clinical Service
Study Locations (1)
Wisconsin
- Marshfield Clinic Research Institute - Marshfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-07-24 |
| Est. Completion | 2025-07 |
What the registry record for NCT05955482 still lists
NCT05955482 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 1 intervention - of which NuvoAir Clinical Service is the first listed.
NCT05955482 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05955482 about?
NCT05955482 is a clinical study titled "Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients With Chronic Obstructive Pulmonary Disease". This is a 12 month study of up to 500 people with COPD to determine if the NuvoAir clinical service leads to lower rates of severe COPD exacerbations, hospitalizations, emergency room visits, and total cost of care compared to a similar group that doesn't receive care from the NuvoAir clinical servi...
What is the current status of trial NCT05955482?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2023-07-24. Estimated completion is 2025-07.
What conditions does trial NCT05955482 study?
This clinical trial studies the following conditions: COPD, Comorbidities and Coexisting Conditions.
What interventions are being tested in trial NCT05955482?
The interventions under investigation include: NuvoAir Clinical Service (OTHER).
Who is sponsoring clinical trial NCT05955482?
This trial is sponsored by NuvoAir Medical PC, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05955482 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05955482's enrollment target sits among peer trials
300 23rd of 85 higher than 63 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIV
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI